Alisol B, A Novel Inhibitor of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ Atpase Pump, Induces Autophagy, Endoplasmic Reticulum Stress, and Apoptosis
Betty Y. K. Law,Mingfu Wang,Dik-Lung Ma,Fawaz Al-Mousa,Francesco Michelangeli,Suk-Hang Cheng,Margaret H. L. Ng,Ka-Fai To,Anthony Y. F. Mok,Rebecca Y. Y. Ko,Sze Kui Lam,Feng Chen,Chi-Ming Che,Pauline Chiu,Ben C. B. Ko
DOI: https://doi.org/10.1158/1535-7163.mct-09-0700
2010-01-01
Molecular Cancer Therapeutics
Abstract:Emerging evidence suggests that autophagic modulators have therapeutic potential. This study aims to identify novel autophagic inducers from traditional Chinese medicinal herbs as potential antitumor agents. Using an image-based screen and bioactivity-guided purification, we identified alisol B 23-acetate, alisol A 24-acetate, and alisol B from the rhizome of Alisma orientale as novel inducers of autophagy, with alisol B being the most potent natural product. Across several cancer cell lines, we showed that alisol B-treated cells displayed an increase of autophagic flux and formation of autophagosomes, leading to cell cycle arrest at the G(1) phase and cell death. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, we showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase. This study provides detailed insights into the cytotoxic mechanism of a novel antitumor compound. Mol Cancer Ther; 9(3); 718-30. (C) 2010 AACR.